Bimzelx® (bimekizumab-bkzx) Has Arrived!
BIMZELX® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
▶︎
How to Treat the Root Cause of Psoriasis: The Gut Microbiome
▶︎
Ep133: HS Treatment Pipeline Explosion: What's New & What's Next | The Future of Dermatology Podcast
▶︎
Audrey and Cheryl chat about 2026 IPPS updates
▶︎
Beautymaxxing: What's Real in Cosmetic Dermatology?
▶︎
Self-Injecting Bimekizumab? Here's How to Do It Right
▶︎
C4T Meeting - Dr. Evan Lewis
▶︎
JUNE 2026 | Investor Update
▶︎
How to Become Clinical Trial Ready, Using the Optune Gio Device for GBM/rGBM & FORTE Clinical Trial
▶︎
An integrated blueprint for clinical excellence and revenue integrity
▶︎
How Sugar & Processed Foods Impact Your Health | Dr. Robert Lustig
▶︎
Dairy Reproduction & Mycotoxins: Hidden Threats to Pregnancy Success
▶︎
Drugs for Heart Failure
▶︎
Psoriasis Treatment Answers- What I Ate, Supplements, and Lifestyle
▶︎
Oncology Grand Rounds: Biomarker Treatment Strategies & Emerging Therapeutic Targets - June 8, 2026
▶︎
What is PRURIGO NODULARIS: Treatment to STOP the CRAZY ITCH | Shawn Kwatra
▶︎
A New Approach to von Willebrand Disease Treatment | Girls Bleed Too + CHES + HEMAB
▶︎
The Relative Benefits and Risks of Kratom Derived Products
▶︎
Acne as Procedural Dermatology
▶︎
This Common Food Is Feeding Your Cancer Cells - Dr. William Li
▶︎